Question 1

What’s the financial overview for 3320.HK?

Accepted Answer

3320.HK’s market cap stands at HK$0.03 trillion right now. The company’s trailing twelve-month earnings per share EPS is HK$0.58, with a dividend yield of 2.78%. Their next earnings report is set for January 29, 2025, and the estimated EPS for that period is $1.61. You can also check out summaries of their income statement, balance sheet, and cash flow details for a fuller picture of their financials.

Question 2

How can I analyze historical data?

Accepted Answer

To analyze historical data with AI tools, apply the date range filter above the table to focus on a specific period. The table displays daily open, high, low, close prices, and volume, enabling you to spot trends and patterns. Use these insights to make informed decisions based on historical performance.

Question 3

What does 3320.HK Stock ROE tell us?

Accepted Answer

3320.HK stock ROE shows positive market sentiment. A higher ROE means the company’s management is doing a better job at using equity financing to drive income and growth. It’s a handy metric for comparing how a company stacks up against its competitors or the broader market.

Question 4

What is per share price for 3320.HK?

Accepted Answer

The 3320.HK stock per share price is HK$5.28.

China Resources Pharmaceutical Group Limited

Unlock 25+ Years of Financial Data

Frequently Asked Questions

What’s the financial overview for 3320.HK?

How can I analyze historical data?

What does 3320.HK Stock ROE tell us?

What is per share price for 3320.HK?